Case number 1:20-cv-01182
Astellas US LLC et al v. Meitheal Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 27, 2021 | 16 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (Attachments: # (1) Stipulation)(fms) |
| Jan 27, 2021 | 16 | Stipulation (2) |
| Jan 27, 2021 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re [15] Stipulation of Dismissal filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC, ***Civil Case Terminated. Ordered by Judge Colm F. Connolly on 1/27/2021. (fms) (nmf, ). |
| Jan 27, 2021 | 18 | Remark (2) Docket Text: Remark: A signed pdf order of the Stipulation and Order of Dismissal re: today's "So Ordered" has been added to the docket per request of Defendant. (nmf) |
| Jan 26, 2021 | 15 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jan 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] STIPULATION TO EXTEND TIME Proposed Scheduling Order to February 5, 2021 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 1/22/2021. (fms) |
| Jan 22, 2021 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Proposed Scheduling Order to February 5, 2021 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Dec 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] STIPULATION TO EXTEND TIME Proposed Scheduling Order to January 22, 2021 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 12/18/2020. (fms) |
| Dec 18, 2020 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Proposed Scheduling Order to January 22, 2021 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Nov 19, 2020 | 12 | Order (1) Docket Text: ORDER, IT IS ORDERED that, on or before December 21 2020, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/21/2020.) Signed by Judge Colm F. Connolly on 11/19/2020. (nmf) |
| Oct 14, 2020 | 11 | Answer to Counterclaim (9) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Sep 25, 2020 | 9 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Meitheal Pharmaceuticals, Inc..(Dorsney, Kenneth) |
| Sep 25, 2020 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hong Kong King Friend Industrial Co. Ltd. for Meitheal Pharmaceuticals, Inc. filed by Meitheal Pharmaceuticals, Inc.. (Dorsney, Kenneth) |
| Sep 9, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Sep 9, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. Meitheal Pharmaceuticals, Inc. served on 9/4/2020, answer due 9/25/2020. (Oakes, Robert) |
| Sep 4, 2020 | 1 | Exhibit A (22) |
| Sep 4, 2020 | 1 | Exhibit B (22) |
| Sep 4, 2020 | 1 | Exhibit C (20) |
| Sep 4, 2020 | 1 | Exhibit D (18) |
| Sep 4, 2020 | 1 | Civil Cover Sheet (1) |
| Sep 4, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Sep 4, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 18, 2020. Date of Expiration of Patent: February 2, 2027.Thirty Month Stay Deadline: 2/18/2023. (myr) |
| Sep 4, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (myr) |
| Sep 4, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (myr) |
| Sep 4, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (myr) |
| Sep 4, 2020 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Sep 4, 2020 | 1 | Complaint* (1) |
